Edan Instruments

Edan Instruments Earnings CAGR 10Y

The Earnings CAGR (10 Year) of Edan Instruments (300206.SZ) as of Oct 25, 2026 is 11.47 %. In the previous year, Earnings CAGR (10 Year) was 11.47 % — a change of 0.00% (lower).

Earnings CAGR 10Y

11.47 %

YoY

0.00%

Last updated:

Earnings CAGR (10 Year) of Edan Instruments is 2025 11.47 % . Earnings CAGR (10 Year) of Edan Instruments was 2024 11.47 % . It decreases by 0.00% lower compared to the previous year.

The Edan Instruments Earnings CAGR 10Y history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Earnings CAGR 10Y
Date
Earnings CAGR 10Y
Jan 1, 2018
11.47 CNY
Jan 1, 2019
11.47 CNY
Jan 1, 2020
11.47 CNY
Jan 1, 2021
11.47 CNY
Jan 1, 2022
11.47 CNY
Jan 1, 2023
11.47 CNY
Jan 1, 2024
11.47 CNY
Jan 1, 2025
11.47 CNY
The Edan Instruments Earnings CAGR 10Y history
YEAREarnings CAGR 10YYoY
11.47 %0.00%
11.47 %0.00%
11.47 %0.00%
11.47 %0.00%
11.47 %0.00%
11.47 %0.00%
11.47 %0.00%
11.47 %0.00%
11.47 %0.00%
11.47 %0.00%
11.47 %0.00%
11.47 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Edan Instruments Stock analysis

What does Edan Instruments do? Edan Instruments, Inc. generates revenue through the design, manufacture, and sale of medical equipment, including maternity product series like doppler fetal heart beat monitors, ultrasonic doppler fetal heart beat monitors, fetal/maternal monitors, and maternity integrated diagnostic monitoring systems. The company also sells electrocardiograph series such as digital twelve-channel electrocardiographs, digital six-channel electrocardiographs, and electrocardiographic workstations, along with monitoring products like portable multi-variable monitors and central monitoring systems. Additionally, Edan offers spare parts and in vitro diagnostics products to support its equipment and medical services. The primary buyers of Edan's products are healthcare institutions, including hospitals and clinics, which purchase medical devices for diagnostic and monitoring purposes. These institutions rely on Edan's maternity, electrocardiograph, and monitoring systems to provide patient care. The company's in vitro diagnostics products are also sold to medical facilities for laboratory testing needs. Edan's product segments are defined by medical equipment categories: maternity, electrocardiograph, monitoring, and ultrasonic image systems. The spare parts and in vitro diagnostics businesses complement these segments by providing essential accessories and diagnostic tools. Revenue is derived from direct sales of these products to healthcare providers, with no mention of third-party distribution or additional services beyond the described offerings. Edan Instruments is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Edan Instruments stock

Earnings CAGR (10 Year) of Edan Instruments is 11.47 % in 2025.

On Eulerpool you can find the complete historical development of Earnings CAGR (10 Year) Edan Instruments since 2006 – with annual values, charts, and detailed analysis.

The 10-year earnings CAGR shows the long-term compound annual growth rate of net income over a full decade.

To evaluate Earnings CAGR (10 Year)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Earnings CAGR (10 Year).

Earnings CAGR (10 Year)'s is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Earnings CAGR (10 Year)'s Edan Instruments historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Edan Instruments

All Key Metrics — Edan Instruments